Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BTMD Biote Corp.

Market Closed 03-21 16:00:00 EDT

3.86

-0.34

-8.10%

盘后3.92

+0.06+1.55%

17:41 EDT

High4.19	Low3.81	Vol230.72K
Open4.12	D1 Closing4.20	Amplitude9.05%
Mkt Cap209.74M	Tradable Cap92.83M	Total Shares54.34M
T/O909.92K	T/O Rate0.96%	Tradable Shares24.05M
P/B-1.98	ROE--	EPS0.09
52wk High8.44	52wk Low3.04	P/E42.89
Dividend0.00	Div.Yield0.00	ROA16.96%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BTMD","market":"US","secType":"STK","nameCN":"Biote Corp.","latestPrice":3.86,"timestamp":1742587200000,"preClose":4.2,"halted":0,"volume":230717,"hourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.86,"latestTime":"17:41 EDT","volume":9234,"amount":35698.59,"timestamp":1742593292556},"delay":0,"floatShares":24047990,"shares":54337138,"eps":0.09,"marketStatus":"Market Closed","change":-0.34,"latestTime":"03-21 16:00:00 EDT","open":4.12,"high":4.19,"low":3.81,"amount":909915.316903,"amplitude":0.090476,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.09,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1742803200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":4.2,"preHourTrading":{"tag":"盘前","latestPrice":4.2,"preClose":4.2,"latestTime":"09:29 EDT","volume":16,"amount":67.2,"timestamp":1742563747377},"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.86,"latestTime":"17:41 EDT","volume":9234,"amount":35698.59,"timestamp":1742593292556},"volumeRatio":0.49195068485330307},"requestUrl":"/m/hq/s/BTMD","defaultTab":"news","newsList":[{"id":"2520340094","title":"Marc Beer Buys Handful Of Shares In biote","url":"https://stock-news.laohu8.com/highlight/detail?id=2520340094","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520340094?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:17","pubTimestamp":1742465842,"startTime":"0","endTime":"0","summary":"Investors who take an interest in biote Corp.  should definitely note that the Executive Chairman, Marc Beer, recently paid US$3.87 per share to buy US$417k worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.The Last 12 Months Of Insider Transactions At biote. The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest biote insiders are well aligned, and that they may think the share price is too low. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Our analysis shows 4 warning signs for biote (1 is potentially serious!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marc-beer-buys-handful-shares-101722784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2520848311","title":"biote (BTMD) Gets a Buy from Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2520848311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520848311?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 20:47","pubTimestamp":1742388444,"startTime":"0","endTime":"0","summary":"In a report released today, Alex Fuhrman from Craig-Hallum maintained a Buy rating on biote (BTMD – Research Report). The company’s shares closed y...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biote-btmd-gets-a-buy-from-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biote-btmd-gets-a-buy-from-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2520953130","title":"Biote Announces Purchase of Shares by Directors and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2520953130","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520953130?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 05:30","pubTimestamp":1742333400,"startTime":"0","endTime":"0","summary":"IRVING, Texas, March 18, 2025----biote Corp.   a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote’s common stock, acquiring an aggregate of approximately 260,000 shares.Marc Beer, Biote Executive Chairman, said, \"These share purchases underscore the collective confidence of Biote’s Board members and CEO Bret Christensen in the Company’s business strategy and long-term outlook. The board is very confident in Bret’s ability to make decisive and material changes at Biote to grow our business. With his deep expertise spanning the diagnostic, therapeutic and medical device health care sectors, we believe Bret is exceptionally qualified to lead Biote’s next level of business growth.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-announces-purchase-shares-directors-213000258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2520659590","title":"biote (BTMD) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2520659590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520659590?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 10:25","pubTimestamp":1742264720,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Les Sulewski maintained a Buy rating on biote (BTMD – Research Report) yesterday and set a price target of $7.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biote-btmd-receives-a-buy-from-truist-financial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biote-btmd-receives-a-buy-from-truist-financial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTMD","BK4007"],"gpt_icon":0},{"id":"2520563784","title":"BTMD Buy Rating: Balancing Operational Efficiency and Long-term Growth Amidst Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2520563784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520563784?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 09:15","pubTimestamp":1742260509,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Jonna Kim maintained a Buy rating on biote (BTMD – Research Report) yesterday and set a price target of $6.00. Jonna Kim has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/btmd-buy-rating-balancing-operational-efficiency-and-long-term-growth-amidst-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/btmd-buy-rating-balancing-operational-efficiency-and-long-term-growth-amidst-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTMD"],"gpt_icon":0},{"id":"2519857808","title":"biote Full Year 2024 Earnings: EPS Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2519857808","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519857808?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 19:20","pubTimestamp":1741951221,"startTime":"0","endTime":"0","summary":"NasdaqGM:BTMD Revenue and Expenses Breakdown March 14th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue was in line with analyst estimates. Earnings per share  missed analyst estimates by 44%.In the last 12 months, the only revenue segment was Pharmaceuticals contributing US$197.2m. The largest operating expense was General & Administrative costs, amounting to US$107.5m . Explore how BTMD's revenue and expenses shape its earnings.Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Pharmaceuticals industry in the US.The company's shares are down 27% from a week ago.You still need to take note of risks, for example - biote has   4 warning signs    we think you should know about.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-full-2024-earnings-eps-112021740.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BTMD"],"gpt_icon":0},{"id":"2519582748","title":"Biote Q4 2024 GAAP EPS $0.10, Inline, Sales $49.834M Miss $51.245M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2519582748","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519582748?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 22:47","pubTimestamp":1741877220,"startTime":"0","endTime":"0","summary":"Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 44.44 percent decrease over earnings of $0.18 per share from the same period last year.  The company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44305324/biote-q4-2024-gaap-eps-0-10-inline-sales-49-834m-miss-51-245m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Biote Q4 2024 GAAP EPS $0.10, Inline, Sales $49.834M Miss $51.245M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTMD"],"gpt_icon":0},{"id":"2519783249","title":"Biote Is Maintained at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2519783249","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519783249?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 21:47","pubTimestamp":1741873620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 13, 2025 09:47 ET (13:47 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTMD"],"gpt_icon":0},{"id":"2519831473","title":"Biote price target lowered to $8 from $12 at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831473?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 20:51","pubTimestamp":1741870287,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Alex Fuhrman lowered the firm’s price target on Biote (BTMD) to $8 from $12 and keeps a Buy rating on the shares. The firm say...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biote-price-target-lowered-to-8-from-12-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biote-price-target-lowered-to-8-from-12-at-craig-hallum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BTMD","BK4007"],"gpt_icon":0},{"id":"2519833638","title":"biote (BTMD) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833638?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:37","pubTimestamp":1741865849,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Les Sulewski maintained a Buy rating on biote (BTMD – Research Report) today and set a price target of $7.00. The company’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biote-btmd-gets-a-buy-from-truist-financial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biote-btmd-gets-a-buy-from-truist-financial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2519888029","title":"Q4 2024 Biote Corp Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2519888029","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519888029?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:03","pubTimestamp":1741863790,"startTime":"0","endTime":"0","summary":"Marc Beer; Executive Chairman of the Board; Biote Corp. Bret Christensen; Chief Executive Officer, Principal Executive Officer, Director; Biote Corp. Good day and welcome to the Biote fourth quarter 2024 earnings conference call.  Please note that this event is being recorded. I would now like to turn the conference over to Simon Serroviey at Investor Relations. Please go ahead.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-biote-corp-earnings-110310818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BTMD"],"gpt_icon":0},{"id":"2519884419","title":"Truist Securities Adjusts Price Target on biote to $7 From $9, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2519884419","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519884419?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 18:33","pubTimestamp":1741861988,"startTime":"0","endTime":"0","summary":"biote (BTMD) has an average rating of buy and mean price target of $9.54, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and rese","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BTMD"],"gpt_icon":0},{"id":"2519257005","title":"Biote Corp (BTMD) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Initiatives ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2519257005","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519257005?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 15:09","pubTimestamp":1741849799,"startTime":"0","endTime":"0","summary":"Revenue: $49.8 million for Q4 2024, up 9% year-over-year.Procedure Revenue Growth: Increased 5%, impacted by transition to new software and training focus.Dietary Supplement Revenue: Increased 10.2% year-over-year, benefiting from transition to Amazon Channel.Gross Profit Margin: 71.8%, a 247 basis point increase from Q4 2023.Selling, General and Administrative Costs: $33.0 million, up from $26.2 million in Q4 2023.Net Income: $3.5 million, compared to $12.1 million in Q4 2023.Net Income Per Share: $0.10 per diluted share, down from $0.18 in Q4 2023.Adjusted EBITDA: $15.1 million, up 11.4%, with a margin of 30.3%.Cash Flow from Operations: $45.2 million for fiscal year 2024, up from $26.9 million in 2023.Cash and Cash Equivalents: $39.3 million as of December 31, 2024.2025 Revenue Outlook: $202 million to $208 million.2025 Adjusted EBITDA Outlook: $59 million to $64 million.Biote Corp  reported a 9% increase in fourth-quarter revenue, reaching $49.8 million.Q: Can you help us reconcile","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-corp-btmd-q4-2024-070959833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BTMD"],"gpt_icon":0},{"id":"2519107948","title":"Biote Corp. Reports Solid 2024 Financial Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2519107948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519107948?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 12:09","pubTimestamp":1741838989,"startTime":"0","endTime":"0","summary":"Biote Corp. ( ($BTMD) ) has released its Q4 earnings. Here is a breakdown of the information Biote Corp. presented to its investors. Biote Corp., a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biote-corp-reports-solid-2024-financial-performance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biote-corp-reports-solid-2024-financial-performance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRUG","SPRB","BIRD","SID","BTMD","SKIN","AFCG","DKS","ATLC","SKYX","SSP","ACHV","MNTK","MGTX","ARCO","ONDS","QRHC","NOA","RMBL","EBR","HLLY","LEGN","ABM","WSM","KRMD","TH","BZ","PHLT","FTCI","BBCP","EXK","LRMR","AKBA","APYX","KSS","EWCZ","BLDE","KFY","S","VTS","WEST","KALV","BW","AGEN","ASRT","SMSI","ZYXI","BWAY","UNFI"],"gpt_icon":1},{"id":"2518200801","title":"Biote Corp  expected to post earnings of 10 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200801","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518200801?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 04:04","pubTimestamp":1741637047,"startTime":"0","endTime":"0","summary":"Biote Corp  expected to post earnings of10cents a share - Earnings Preview Biote Corp BTMD.OQ BTMD.O is expected to show a rise in quarterly revenue when it reports  results on March 12 for the period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL8N3PT223:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTMD"],"gpt_icon":0},{"id":"2517859394","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517859394","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517859394?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 19:00","pubTimestamp":1741345200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Algonquin Pwr & Utl                              4Q       .09       BMO. ·Asana Inc. Class A                              4Q      (.01)  4:05 PM. ·Auna S.A. Class A                               4Q       .15       AMC. ·Vail Resorts Inc.                                2Q      6.29   4:05 PM","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVEX","BNTX","SSP","MOMO","MYPS","CVGW","BW","AEO","VTS","CINT","TBRG","KRMD","ASRT","CIEN","HLLY","BTMD","ADBE","ATLC","ARCO","KALV","LE","DRRX","BDTX","CDTX","ORCL","NKTR","FTCI","LRMR","URGN","CING","DRUG","NOA","FERG","CHRS","ZVRA","LMB","AMRN","WEST","MGTX","AURA","BBCP","LEN.B","ACET","BWMN","SFIX","AUNA","EWCZ","DKS","GECC"],"gpt_icon":1},{"id":"2514808898","title":"Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2514808898","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514808898?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"IRVING, Texas, February 26, 2025----biote Corp.  , a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 12, 2025, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET. the same day.The conference call may be accessed by dialing  481-2820  or  317-0679 . The live webcast of the call can be accessed using the following link: biote Corp. Fourth Quarter Earnings Call. A replay of the webcast will be available on the Events page of the Biote Investor Relations website, found here, shortly after the event concludes.Biote is transforming healthy aging through innovative, personalized hormone optimization and therapeutic wellness solutions delivered by Biote-certified medical providers. Biote trains practitioners to identify and treat early indicato","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biote-schedules-fourth-quarter-full-210500818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BTMD","BK4007"],"gpt_icon":0},{"id":"2507604048","title":"BRIEF-Biote Announces CEO Retirement And Succession Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2507604048","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507604048?lang=en_us&edition=full_marsco","pubTime":"2025-01-31 07:28","pubTimestamp":1738279682,"startTime":"0","endTime":"0","summary":"BRIEF-Biote Announces CEO Retirement And Succession Planbiote Corp BTMD.O:BIOTE ANNOUNCES CEO RETIREMENT AND SUCCESSION PLANBIOTE CORP - TERRY WEBER RETIRING AS CEO EFFECTIVE FEBRUARY 1, 2025BIOTE COR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA9DMGQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BTMD"],"gpt_icon":0},{"id":"2507606316","title":"Biote Names Christensen as CEO Upon Weber's Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2507606316","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507606316?lang=en_us&edition=full_marsco","pubTime":"2025-01-31 05:47","pubTimestamp":1738273620,"startTime":"0","endTime":"0","summary":"Biote said Chief Executive Officer Terry Weber is expected to retire effective Feb. 1, and would be succeeded by Bret Christensen.The hormone- and therapeutic-health and wellness company said Weber will advise the company's board of directors.Christensen has over two decades of leadership experience in the healthcare industry, Biote said, and has worked at Hologic, Myriad Genetics and Insulet.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTMD","WEBR","BK4191","BK4007","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biote.com","stockEarnings":[{"period":"1week","weight":0.0266},{"period":"1month","weight":-0.2122},{"period":"3month","weight":-0.3672},{"period":"6month","weight":-0.3599},{"period":"1year","weight":-0.3834},{"period":"ytd","weight":-0.3754}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":-0.0799},{"period":"3month","weight":-0.046},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.08},{"period":"ytd","weight":-0.0377}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.074462},{"month":2,"riseRate":0.5,"avgChangeRate":0.139199},{"month":3,"riseRate":0.5,"avgChangeRate":0.047619},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.000777},{"month":5,"riseRate":0.25,"avgChangeRate":-0.078544},{"month":6,"riseRate":0.5,"avgChangeRate":-0.018825},{"month":7,"riseRate":0.75,"avgChangeRate":0.019879},{"month":8,"riseRate":0.25,"avgChangeRate":-0.082219},{"month":9,"riseRate":0.5,"avgChangeRate":-0.023634},{"month":10,"riseRate":0.75,"avgChangeRate":0.001984},{"month":11,"riseRate":0.25,"avgChangeRate":0.029226},{"month":12,"riseRate":0.25,"avgChangeRate":-0.03326}],"exchange":"NASDAQ","name":"Biote Corp.","nameEN":"Biote Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biote Corp.(BTMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biote Corp.,BTMD,Biote Corp.股票,Biote Corp.股票老虎,Biote Corp.股票老虎国际,Biote Corp.行情,Biote Corp.股票行情,Biote Corp.股价,Biote Corp.股市,Biote Corp.股票价格,Biote Corp.股票交易,Biote Corp.股票购买,Biote Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biote Corp.(BTMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biote Corp.(BTMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction